Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia

Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia

While the positive association between automated intact fibroblast growth factor (FGF) 23 measurement kit (Determinar CL FGF23 [CL]) and the former assay (Kainos [KI]), and clinical utility of CL was well established, the clinical performance of Medfrontier FGF23 (MED), which was the manual intact F...

Full description

Bibliographic Details
Main Authors: Hajime Kato, Hiromi Miyazaki, Takehide Kimura, Yoshitomo Hoshino, Naoko Hidaka, Minae Koga, Masaomi Nangaku, Noriko Makita, Nobuaki Ito
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Bone Reports
Subjects:
Fibroblast growth factor 23
Immunoassay
Hypophosphatemia
X-linked hypophosphatemic rickets/osteomalacia
Tumor-induced osteomalacia
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187223000074

Internet

http://www.sciencedirect.com/science/article/pii/S2352187223000074

Similar Items